| __timestamp | Jazz Pharmaceuticals plc | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 406114000 | 1213000 |
| Thursday, January 1, 2015 | 449119000 | 3425000 |
| Friday, January 1, 2016 | 502892000 | 6311000 |
| Sunday, January 1, 2017 | 544156000 | 9518000 |
| Monday, January 1, 2018 | 683530000 | 28080000 |
| Tuesday, January 1, 2019 | 736942000 | 36550000 |
| Wednesday, January 1, 2020 | 854233000 | 46125000 |
| Friday, January 1, 2021 | 1451683000 | 68486000 |
| Saturday, January 1, 2022 | 1416967000 | 92032000 |
| Sunday, January 1, 2023 | 1343105000 | 117532000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, strategic spending on Selling, General, and Administrative (SG&A) expenses can be a game-changer. Jazz Pharmaceuticals plc and Rhythm Pharmaceuticals, Inc. offer a fascinating study in contrasts over the past decade. From 2014 to 2023, Jazz Pharmaceuticals has consistently outpaced Rhythm Pharmaceuticals in SG&A spending, with a staggering 230% increase, peaking at over 1.34 billion in 2023. In contrast, Rhythm Pharmaceuticals, starting from a modest base, has shown a remarkable growth trajectory, with a nearly 9,600% increase, reaching approximately 118 million in the same year. This divergence highlights Jazz's established market presence and Rhythm's aggressive growth strategy. As the pharmaceutical landscape evolves, these spending patterns may offer insights into each company's strategic priorities and market positioning.
Operational Costs Compared: SG&A Analysis of AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Gilead Sciences, Inc. and Jazz Pharmaceuticals plc
Breaking Down SG&A Expenses: Neurocrine Biosciences, Inc. vs Rhythm Pharmaceuticals, Inc.
Bio-Techne Corporation vs Rhythm Pharmaceuticals, Inc.: SG&A Expense Trends
Walgreens Boots Alliance, Inc. and Jazz Pharmaceuticals plc: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Jazz Pharmaceuticals plc or CymaBay Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Arrowhead Pharmaceuticals, Inc.
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Vericel Corporation Trends and Insights
SG&A Efficiency Analysis: Comparing Halozyme Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Rhythm Pharmaceuticals, Inc.
Comparing SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs MannKind Corporation Trends and Insights
Cost Management Insights: SG&A Expenses for Rhythm Pharmaceuticals, Inc. and MiMedx Group, Inc.